Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Published in: Breast Cancer Research and Treatment 2/1999

01-01-1999

Combined effect of vitamin D3 analogs and paclitaxel on the growth of MCF-7 breast cancer cells in vivo

Authors: Kozo Koshizuka, Michiaki Koike, Hiroya Asou, Steve K. Cho, Tony Stephen, Robert K. Rude, Lise Binderup, Milan Uskokovic, H. Phillip Koeffler

Published in: Breast Cancer Research and Treatment | Issue 2/1999

Login to get access
Metadata
Title
Combined effect of vitamin D3 analogs and paclitaxel on the growth of MCF-7 breast cancer cells in vivo
Authors
Kozo Koshizuka
Michiaki Koike
Hiroya Asou
Steve K. Cho
Tony Stephen
Robert K. Rude
Lise Binderup
Milan Uskokovic
H. Phillip Koeffler
Publication date
01-01-1999
Publisher
Kluwer Academic Publishers
Published in
Breast Cancer Research and Treatment / Issue 2/1999
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1023/A:1006123819675

Other articles of this Issue 2/1999

Breast Cancer Research and Treatment 2/1999 Go to the issue

OriginalPaper

Effect of fenretinide on bone mineral density and metabolism in women with early breast cancer

OriginalPaper

Sentinel lymphadenectomy in breast cancer: identification of sentinel lymph node and detection of metastases

OriginalPaper

Serum VEGF levels in women with a benign breast tumor or breast cancer

OriginalPaper

The declining use of axillary dissection in patients with early stage breast cancer

OriginalPaper

Prognostic factors in patients with isolated recurrences of breast cancer (stage IV-NED)

OriginalPaper

The expression of variant exon v7–v8 CD44 antigen in relation to lymphatic metastasis of human breast cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits